{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:21:01Z","timestamp":1791030061561,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pycnodysostosis is an extremely rare genetic osteosclerosis caused by cathepsin K deficiency. We hypothesized that teriparatide, a potent anabolic agent used in the treatment of osteoporosis, might reduce skeletal fragility by activating bone turnover. We studied a typical case of pycnodysostosis in a 37-yr-old woman who exhibited short stature, skull and thorax deformities, and a history of severe fragility fractures. Cathepsin K gene sequencing was performed. Before and after 6 mo of 20 \u03bcg\/d teriparatide, biochemical markers of bone turnover were measured, and 3D bone structure and microarchitecture was assessed in vivo by HR-pQCT. Qualitative and quantitative analysis of transiliac bone biopsies were performed, and the degree of mineralization was evaluated by quantitative microradiography. In vitro assessment of bone resorption was performed after separation and differentiation of CD14+ monocytes from peripheral blood. Bone structure assessed by HR-pQCT on the radius and tibia showed augmentation of cortical and trabecular density. Transiliac bone biopsy showed highly increased bone mass (+63% versus age- and sex-matched controls), a decrease in bone remodeling without evidence of active osteoblasts, and a severe decrease in the dynamic parameters of bone formation (mineralizing surfaces, \u221290% and bone formation rate, \u221293% versus age- and sex-matched controls). This depressed bone turnover probably explained the increased degree of mineralization. The presence of a novel missense mutation leading to an A141V amino acid substitution confirmed a genetic defect of cathepsin K as the cause of the disease. The deficiency of active osteoclasts was confirmed by an in vitro study that showed a decreased concentration of CD14+ monocytes (the precursor of osteoclasts) in blood. These osteoclasts had low resorptive activity when incubated on bone slices. After 6 mo of teriparatide, the structure, microarchitecture, and turnover of bone\u2014assessed by HR-pQCT, histology, and bone turnover markers\u2014remained unchanged. Our data strongly suggest that some features of the osteoclastic phenotype\u2014that are absent in pycnodysostosis\u2014are a prerequisite for the anabolic effect of PTH on osteoblasts.<\/jats:p>","DOI":"10.1359\/jbmr.080231","type":"journal-article","created":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T09:05:02Z","timestamp":1204016702000},"page":"1076-1083","source":"Crossref","is-referenced-by-count":55,"title":["Mechanisms of the Anabolic Effects of Teriparatide on Bone: Insight From the Treatment of a Patient With Pycnodysostosis"],"prefix":"10.1093","volume":"23","author":[{"given":"Pascale","family":"Chavassieux","sequence":"first","affiliation":[{"name":"INSERM Research Unit 831 and Universit\u00e9 de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[{"name":"Nordic Bioscience A\/S, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Segovia-Silvestre","sequence":"additional","affiliation":[{"name":"Nordic Bioscience A\/S, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita V","family":"Neutzsky-Wulff","sequence":"additional","affiliation":[{"name":"Nordic Bioscience A\/S, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 831 and Universit\u00e9 de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Boivin","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 831 and Universit\u00e9 de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre D","family":"Delmas","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 831 and Universit\u00e9 de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020319515024300_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S8756-3282(96)00351-1","article-title":"Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry","volume":"20","author":"Littlewood-Evans","year":"1997","journal-title":"Bone"},{"key":"2024020319515024300_bib2","first-page":"449","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Whyte","year":"2003","edition":"5th ed"},{"key":"2024020319515024300_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1359\/jbmr.1999.14.10.1654","article-title":"Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization","volume":"14","author":"Gowen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"2024020319515024300_bib5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/jbmr.5650071206","article-title":"Measurements of serum osteocalcin with a human specific two-site immunoradiometric assay","volume":"7","author":"Garnero","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin Chem"},{"key":"2024020319515024300_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","article-title":"Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease","volume":"8","author":"Uebelhart","year":"1990","journal-title":"Bone Miner"},{"key":"2024020319515024300_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S8756-3282(02)00922-5","article-title":"An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis","volume":"32","author":"Garnero","year":"2003","journal-title":"Bone"},{"key":"2024020319515024300_bib10","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","article-title":"In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography","volume":"90","author":"Boutroy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319515024300_bib11","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI111096","article-title":"Relationships between surface, volume and thickness of iliac trabecular bone in aging, and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss","volume":"72","author":"Parfitt","year":"1983","journal-title":"J Clin Invest"},{"key":"2024020319515024300_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/B978-012470862-4\/50064-7","volume-title":"Osteoporosis","author":"Chavassieux","year":"2001","edition":"2nd ed"},{"key":"2024020319515024300_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-001-2048-0","article-title":"The degree of mineralization of bone issue measured by computerized quantitative contact microradiography","volume":"70","author":"Boivin","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"2024020319515024300_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00774-006-0725-9","article-title":"Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood","volume":"25","author":"Sorensen","year":"2007","journal-title":"J Bone Miner Metab"},{"key":"2024020319515024300_bib16","doi-asserted-by":"crossref","first-page":"44975","DOI":"10.1074\/jbc.M303905200","article-title":"Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression","volume":"278","author":"Karsdal","year":"2003","journal-title":"J Biol Chem"},{"key":"2024020319515024300_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jcp.47.6.529","article-title":"Age related histomorphometric changes in bone in normal British men and women","volume":"47","author":"Rehman","year":"1974","journal-title":"J Clin Pathol"},{"key":"2024020319515024300_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0221-8747(83)90004-8","article-title":"Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects","volume":"5","author":"Vedi","year":"1983","journal-title":"Metab Bone Dis Relat Res"},{"key":"2024020319515024300_bib19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","article-title":"Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis","volume":"89","author":"Fratzl-Zelman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319515024300_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/8756-3282(87)90167-0","article-title":"Paramyxovirus-like inclusions in two cases of pycnodysostosis","volume":"8","author":"Beneton","year":"1987","journal-title":"Bone"},{"key":"2024020319515024300_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02557674","article-title":"Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis","volume":"37","author":"Everts","year":"1985","journal-title":"Calcif Tissue Int"},{"key":"2024020319515024300_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1359\/jbmr.2002.17.1.77","article-title":"The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation","volume":"17","author":"Everts","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib23","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1359\/jbmr.1999.14.11.1902","article-title":"Determination of bone markers in pycnodysostosis: Effects of cathepsin K deficiency on bone matrix degradation","volume":"14","author":"Nishi","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib24","doi-asserted-by":"crossref","first-page":"32347","DOI":"10.1074\/jbc.273.48.32347","article-title":"The collagenolytic activity of cathepsin K is unique among mammalian proteinase","volume":"273","author":"Garnero","year":"1998","journal-title":"J Biol Chem"},{"key":"2024020319515024300_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/03008200290000934","article-title":"Changes in bone remodelling rate influence the degree of mineralization of bone","volume":"43","author":"Boivin","year":"2002","journal-title":"Connect Tissue Res"},{"key":"2024020319515024300_bib26","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality: The material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"2024020319515024300_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/er.2006-0029","article-title":"Insights into material and structural basis of bone fragility from diseases associated with fractures: How determinants of the biomechanical properties of bone are compromised by disease","volume":"28","author":"Chavassieux","year":"2007","journal-title":"Endocr Rev"},{"key":"2024020319515024300_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00198-006-0311-y","article-title":"High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K","volume":"18","author":"Schilling","year":"2007","journal-title":"Osteoporos Int"},{"key":"2024020319515024300_bib29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","article-title":"Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass","volume":"21","author":"Li","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jcem.85.1.6247","article-title":"Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization","volume":"85","author":"Fujita","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319515024300_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI653","article-title":"Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis","volume":"103","author":"Hou","year":"1999","journal-title":"J Clin Invest"},{"key":"2024020319515024300_bib32","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsy from patients with osteoporosis: A paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319515024300_bib34","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1359\/JBMR.050309","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume":"20","author":"Arlot","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: Early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblasts apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"2024020319515024300_bib37","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","article-title":"Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis; results from a 6-month double-blind placebo-controlled trial","volume":"20","author":"Deal","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","article-title":"The anabolic effect of human PTH(1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2014Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?","volume":"16","author":"Delmas","year":"1995","journal-title":"Bone"},{"key":"2024020319515024300_bib39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination on postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"2024020319515024300_bib40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/8756-3282(93)90190-L","article-title":"Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous bone surfaces","volume":"14","author":"Hodsman","year":"1993","journal-title":"Bone"},{"key":"2024020319515024300_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","article-title":"Are non resorbing osteoclasts sources of bone anabolic activity?","volume":"22","author":"Karsdal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2024020319515024300_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1210\/endo-126-2-955","article-title":"Osteopetrosis in the rat: Coexistence of reduction in osteocalcin and bone resorption","volume":"126","author":"Lian","year":"1990","journal-title":"Endocrinology"},{"key":"2024020319515024300_bib43","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1210\/en.2002-220221","article-title":"Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos","volume":"143","author":"Demiralp","year":"2002","journal-title":"Endocrinology"},{"key":"2024020319515024300_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man","volume":"104","author":"Kornack","year":"2001","journal-title":"Cell"},{"key":"2024020319515024300_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","article-title":"Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification","volume":"23","author":"Li","year":"1999","journal-title":"Nat Genet"},{"key":"2024020319515024300_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tem.2004.01.002","article-title":"Does bone resorption inhibition affect the anabolic response to parathyroid hormone?","volume":"15","author":"Martin","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"2024020319515024300_bib47","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/en.2005-0333","article-title":"Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone","volume":"146","author":"Koh","year":"2005","journal-title":"Endocrinology"},{"key":"2024020319515024300_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00187292","article-title":"Simulation of bone resorption-repair coupling in vitro","volume":"190","author":"Jones","year":"1994","journal-title":"Anat Embryol (Berl)"},{"key":"2024020319515024300_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/8756-3282(95)00456-4","article-title":"Topographically induced bone formation in vitro: Implications for bone implants and bone grafts","volume":"18","author":"Gray","year":"1996","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.080231","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/23\/7\/1076\/56570721\/5650230715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/23\/7\/1076\/56570721\/5650230715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:50:38Z","timestamp":1710327038000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/23\/7\/1076-1083\/7599495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.080231","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1120868.577133","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,7,1]]},"published":{"date-parts":[[2008,7,1]]}}}